nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—peripheral nervous system neoplasm	0.937	1	CbGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.00474	0.129	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00286	0.0777	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00247	0.067	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—NME1—peripheral nervous system neoplasm	0.00189	0.0513	CbGpPWpGaD
Etomidate—SLC2A1—Glycolysis and Gluconeogenesis—ENO2—peripheral nervous system neoplasm	0.00175	0.0475	CbGpPWpGaD
Etomidate—CYP11B2—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.00158	0.0429	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.0014	0.038	CbGpPWpGaD
Etomidate—Hypoxia—Tretinoin—peripheral nervous system neoplasm	0.00135	0.0536	CcSEcCtD
Etomidate—Hypoxia—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.0536	CcSEcCtD
Etomidate—Myoclonus—Vincristine—peripheral nervous system neoplasm	0.00104	0.0413	CcSEcCtD
Etomidate—Hypoxia—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.0406	CcSEcCtD
Etomidate—Respiratory failure—Topotecan—peripheral nervous system neoplasm	0.000878	0.035	CcSEcCtD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000877	0.0238	CbGpPWpGaD
Etomidate—Respiratory failure—Tretinoin—peripheral nervous system neoplasm	0.000871	0.0347	CcSEcCtD
Etomidate—Respiratory failure—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.0347	CcSEcCtD
Etomidate—SLC2A1—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00079	0.0214	CbGpPWpGaD
Etomidate—SLC2A1—Carbohydrate metabolism—GNS—peripheral nervous system neoplasm	0.000762	0.0207	CbGpPWpGaD
Etomidate—Ephedrine—BCHE—peripheral nervous system neoplasm	0.000685	1	CrCbGaD
Etomidate—Laryngospasm—Etoposide—peripheral nervous system neoplasm	0.000678	0.027	CcSEcCtD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.000671	0.0182	CbGpPWpGaD
Etomidate—Respiratory failure—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.0263	CcSEcCtD
Etomidate—Respiratory failure—Vincristine—peripheral nervous system neoplasm	0.000636	0.0253	CcSEcCtD
Etomidate—SLC2A1—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.000621	0.0169	CbGpPWpGaD
Etomidate—Apnoea—Etoposide—peripheral nervous system neoplasm	0.000597	0.0238	CcSEcCtD
Etomidate—Hiccups—Cisplatin—peripheral nervous system neoplasm	0.000552	0.022	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000503	0.0137	CbGpPWpGaD
Etomidate—CYP19A1—FSH signaling pathway—BDNF—peripheral nervous system neoplasm	0.000466	0.0126	CbGpPWpGaD
Etomidate—SLC2A1—Carbohydrate metabolism—ENO2—peripheral nervous system neoplasm	0.000462	0.0125	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000451	0.0122	CbGpPWpGaD
Etomidate—GABRB2—Orphan transporters—COX2—peripheral nervous system neoplasm	0.00044	0.0119	CbGpPWpGaD
Etomidate—Hyperventilation—Epirubicin—peripheral nervous system neoplasm	0.000412	0.0164	CcSEcCtD
Etomidate—GABRG2—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000403	0.0109	CbGpPWpGaD
Etomidate—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000384	0.0153	CcSEcCtD
Etomidate—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000384	0.0153	CcSEcCtD
Etomidate—Hyperventilation—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.0152	CcSEcCtD
Etomidate—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000379	0.0151	CcSEcCtD
Etomidate—SLC2A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00037	0.01	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000356	0.00967	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000352	0.00956	CbGpPWpGaD
Etomidate—GABRA1—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000352	0.00955	CbGpPWpGaD
Etomidate—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000324	0.0129	CcSEcCtD
Etomidate—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000324	0.0129	CcSEcCtD
Etomidate—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000323	0.0129	CcSEcCtD
Etomidate—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000323	0.0129	CcSEcCtD
Etomidate—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00032	0.0127	CcSEcCtD
Etomidate—CYP11B1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000309	0.00838	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—PTPN11—peripheral nervous system neoplasm	0.000306	0.0083	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000301	0.00818	CbGpPWpGaD
Etomidate—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000298	0.0119	CcSEcCtD
Etomidate—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000298	0.0119	CcSEcCtD
Etomidate—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000294	0.0117	CcSEcCtD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000294	0.00797	CbGpPWpGaD
Etomidate—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.0116	CcSEcCtD
Etomidate—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000285	0.0114	CcSEcCtD
Etomidate—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000285	0.0114	CcSEcCtD
Etomidate—Hiccups—Epirubicin—peripheral nervous system neoplasm	0.000284	0.0113	CcSEcCtD
Etomidate—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000282	0.0112	CcSEcCtD
Etomidate—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000282	0.0112	CcSEcCtD
Etomidate—ADRA2B—G alpha (z) signalling events—GNAS—peripheral nervous system neoplasm	0.00028	0.0076	CbGpPWpGaD
Etomidate—Pain—Topotecan—peripheral nervous system neoplasm	0.000263	0.0105	CcSEcCtD
Etomidate—Hiccups—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.0105	CcSEcCtD
Etomidate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000261	0.0104	CcSEcCtD
Etomidate—Pain—Tretinoin—peripheral nervous system neoplasm	0.000261	0.0104	CcSEcCtD
Etomidate—Pain—Melphalan—peripheral nervous system neoplasm	0.000258	0.0103	CcSEcCtD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000253	0.00687	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00025	0.00679	CbGpPWpGaD
Etomidate—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00987	CcSEcCtD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000247	0.00671	CbGpPWpGaD
Etomidate—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00978	CcSEcCtD
Etomidate—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.00974	CcSEcCtD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.000241	0.00655	CbGpPWpGaD
Etomidate—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000237	0.00942	CcSEcCtD
Etomidate—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000236	0.00939	CcSEcCtD
Etomidate—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.00899	CcSEcCtD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000218	0.00591	CbGpPWpGaD
Etomidate—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.00861	CcSEcCtD
Etomidate—SLC2A1—Disease—GNS—peripheral nervous system neoplasm	0.000216	0.00586	CbGpPWpGaD
Etomidate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.00849	CcSEcCtD
Etomidate—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00833	CcSEcCtD
Etomidate—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000208	0.00829	CcSEcCtD
Etomidate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.00788	CcSEcCtD
Etomidate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000196	0.00779	CcSEcCtD
Etomidate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000194	0.00773	CcSEcCtD
Etomidate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000194	0.00773	CcSEcCtD
Etomidate—CYP11B2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000194	0.00525	CbGpPWpGaD
Etomidate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00766	CcSEcCtD
Etomidate—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000192	0.00763	CcSEcCtD
Etomidate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000192	0.00763	CcSEcCtD
Etomidate—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000191	0.00761	CcSEcCtD
Etomidate—Pain—Vincristine—peripheral nervous system neoplasm	0.000191	0.00759	CcSEcCtD
Etomidate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000184	0.00733	CcSEcCtD
Etomidate—SLC2A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000181	0.00491	CbGpPWpGaD
Etomidate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000176	0.00702	CcSEcCtD
Etomidate—SLC2A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000173	0.0047	CbGpPWpGaD
Etomidate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000169	0.00672	CcSEcCtD
Etomidate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000169	0.00671	CcSEcCtD
Etomidate—CYP11B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000167	0.00453	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000167	0.00453	CbGpPWpGaD
Etomidate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000159	0.00632	CcSEcCtD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000157	0.00427	CbGpPWpGaD
Etomidate—Pain—Etoposide—peripheral nervous system neoplasm	0.000154	0.00615	CcSEcCtD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000154	0.00418	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000152	0.00412	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000151	0.0041	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000151	0.0041	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000149	0.00404	CbGpPWpGaD
Etomidate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.00586	CcSEcCtD
Etomidate—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00577	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000145	0.00393	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000145	0.00393	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000143	0.00389	CbGpPWpGaD
Etomidate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000142	0.00564	CcSEcCtD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000141	0.00382	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—HRAS—peripheral nervous system neoplasm	0.000135	0.00365	CbGpPWpGaD
Etomidate—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00534	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000133	0.0036	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000132	0.00359	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ENO2—peripheral nervous system neoplasm	0.000131	0.00355	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000131	0.00355	CbGpPWpGaD
Etomidate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00507	CcSEcCtD
Etomidate—CYP19A1—FSH signaling pathway—AKT1—peripheral nervous system neoplasm	0.000126	0.00342	CbGpPWpGaD
Etomidate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000125	0.00499	CcSEcCtD
Etomidate—SLC2A1—Insulin Signaling—AKT1—peripheral nervous system neoplasm	0.000119	0.00322	CbGpPWpGaD
Etomidate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00469	CcSEcCtD
Etomidate—GABRA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000116	0.00314	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000115	0.00312	CbGpPWpGaD
Etomidate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000115	0.00457	CcSEcCtD
Etomidate—CYP11B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000113	0.00306	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000111	0.00301	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00011	0.00299	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00011	0.00297	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000109	0.00295	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000108	0.00293	CbGpPWpGaD
Etomidate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00428	CcSEcCtD
Etomidate—GABRB2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000107	0.00292	CbGpPWpGaD
Etomidate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00426	CcSEcCtD
Etomidate—GABRG2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000101	0.00275	CbGpPWpGaD
Etomidate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.00396	CcSEcCtD
Etomidate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.00394	CcSEcCtD
Etomidate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.00393	CcSEcCtD
Etomidate—GABRG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.83e-05	0.00267	CbGpPWpGaD
Etomidate—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.00377	CcSEcCtD
Etomidate—CYP11B2—Metabolism—GNS—peripheral nervous system neoplasm	9.45e-05	0.00257	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.45e-05	0.00257	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.36e-05	0.00254	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—BCHE—peripheral nervous system neoplasm	9.25e-05	0.00251	CbGpPWpGaD
Etomidate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.00364	CcSEcCtD
Etomidate—CYP11B2—Metabolism—NME1—peripheral nervous system neoplasm	9.06e-05	0.00246	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	8.96e-05	0.00243	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—BCHE—peripheral nervous system neoplasm	8.86e-05	0.00241	CbGpPWpGaD
Etomidate—ADRA2B—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	8.84e-05	0.0024	CbGpPWpGaD
Etomidate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.00348	CcSEcCtD
Etomidate—CYP11B2—Metabolism—COX2—peripheral nervous system neoplasm	8.72e-05	0.00237	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TH—peripheral nervous system neoplasm	8.7e-05	0.00236	CbGpPWpGaD
Etomidate—Pain—Epirubicin—peripheral nervous system neoplasm	8.66e-05	0.00345	CcSEcCtD
Etomidate—GABRA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.59e-05	0.00233	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	8.53e-05	0.00232	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	8.33e-05	0.00226	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GNS—peripheral nervous system neoplasm	8.15e-05	0.00221	CbGpPWpGaD
Etomidate—Pain—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.00319	CcSEcCtD
Etomidate—CYP11B1—Metabolism—NME1—peripheral nervous system neoplasm	7.81e-05	0.00212	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—COX2—peripheral nervous system neoplasm	7.52e-05	0.00204	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	7.46e-05	0.00203	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	7.46e-05	0.00202	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GNAS—peripheral nervous system neoplasm	7.1e-05	0.00193	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.97e-05	0.00189	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	6.78e-05	0.00184	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	6.5e-05	0.00176	CbGpPWpGaD
Etomidate—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.00256	CcSEcCtD
Etomidate—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.39e-05	0.00173	CbGpPWpGaD
Etomidate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.00237	CcSEcCtD
Etomidate—ADRA2B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	5.9e-05	0.0016	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTPN11—peripheral nervous system neoplasm	5.89e-05	0.0016	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.87e-05	0.00159	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ENO2—peripheral nervous system neoplasm	5.73e-05	0.00155	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.69e-05	0.00154	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	5.66e-05	0.00154	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.4e-05	0.00147	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.31e-05	0.00144	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.2e-05	0.00141	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	5.17e-05	0.0014	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.98e-05	0.00135	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ENO2—peripheral nervous system neoplasm	4.94e-05	0.00134	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	4.92e-05	0.00134	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—BCHE—peripheral nervous system neoplasm	4.84e-05	0.00131	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB2—peripheral nervous system neoplasm	4.66e-05	0.00126	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KNG1—peripheral nervous system neoplasm	4.62e-05	0.00125	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	4.62e-05	0.00125	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.62e-05	0.00125	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	4.58e-05	0.00124	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.57e-05	0.00124	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TH—peripheral nervous system neoplasm	4.55e-05	0.00123	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.55e-05	0.00123	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	4.52e-05	0.00123	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.52e-05	0.00123	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.49e-05	0.00122	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	4.47e-05	0.00121	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	4.43e-05	0.0012	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	4.26e-05	0.00116	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.18e-05	0.00114	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—BCHE—peripheral nervous system neoplasm	4.17e-05	0.00113	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.13e-05	0.00112	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	4.13e-05	0.00112	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.11e-05	0.00111	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GNAS—peripheral nervous system neoplasm	4.04e-05	0.0011	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.98e-05	0.00108	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TH—peripheral nervous system neoplasm	3.92e-05	0.00106	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HGF—peripheral nervous system neoplasm	3.85e-05	0.00104	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	3.76e-05	0.00102	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GNAS—peripheral nervous system neoplasm	3.71e-05	0.00101	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.66e-05	0.000993	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.64e-05	0.000989	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	3.61e-05	0.00098	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.59e-05	0.000974	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NRAS—peripheral nervous system neoplasm	3.54e-05	0.000962	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	3.49e-05	0.000946	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.39e-05	0.000921	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.34e-05	0.000907	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—peripheral nervous system neoplasm	3.3e-05	0.000896	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GNAS—peripheral nervous system neoplasm	3.2e-05	0.000869	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.18e-05	0.000862	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.14e-05	0.000852	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.11e-05	0.000843	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.92e-05	0.000792	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.81e-05	0.000762	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.8e-05	0.000759	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.71e-05	0.000737	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.65e-05	0.000719	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.64e-05	0.000717	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.6e-05	0.000706	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HRAS—peripheral nervous system neoplasm	2.59e-05	0.000704	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.55e-05	0.000693	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.44e-05	0.000662	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.38e-05	0.000646	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.36e-05	0.000641	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.32e-05	0.000629	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—peripheral nervous system neoplasm	2.29e-05	0.000621	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.25e-05	0.000612	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	2.22e-05	0.000603	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.12e-05	0.000574	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HRAS—peripheral nervous system neoplasm	2.08e-05	0.000564	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.92e-05	0.00052	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.83e-05	0.000497	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.81e-05	0.000492	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.78e-05	0.000483	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	1.69e-05	0.000458	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.61e-05	0.000437	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.57e-05	0.000425	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.49e-05	0.000405	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.37e-05	0.000372	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	1.29e-05	0.00035	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	1.23e-05	0.000335	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000296	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—peripheral nervous system neoplasm	1e-05	0.000272	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.69e-06	0.000263	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.52e-06	0.000258	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—peripheral nervous system neoplasm	8.64e-06	0.000234	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.52e-06	0.000204	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.09e-06	0.000192	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.89e-06	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.83e-06	0.000185	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.26e-06	0.00017	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.72e-06	0.000155	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.33e-06	0.000145	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.9e-06	0.000133	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.38e-06	0.000119	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.19e-06	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.7e-06	0.0001	CbGpPWpGaD
